Mechanistically, ZER-LCNs inhibited cancer cell proliferation and migration by upregulating the mRNA levels of P53 and PTEN, downregulating the mRNA levels of KRT18, as well as by downregulating the levels of several proteins involved in the promotion of cancer cell proliferation, migration, and invasion. Here, KRT18 is linked to cancer.